|
Re: Why I think it's a homerun
|
4
|
Resverlogix Corp.
|
Mar 04, 2019 11:46AM
|
|
Re: I would have thought we'd see more volume....
|
4
|
Resverlogix Corp.
|
Sep 14, 2018 01:55PM
|
|
Re: Question about Phase 2
|
4
|
Resverlogix Corp.
|
Mar 12, 2019 11:59AM
|
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
4
|
Resverlogix Corp.
|
May 29, 2019 05:07PM
|
|
Re: Bear
|
4
|
Resverlogix Corp.
|
Nov 09, 2017 11:14AM
|
|
Re: CHF
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 07:56PM
|
|
Re: Biogen soars -- finds link between amyloid beta and Alzheimer's
|
4
|
Resverlogix Corp.
|
Jul 06, 2018 04:31PM
|
|
New RVX-208 paper on downregulation of the complement cascade
|
4
|
Resverlogix Corp.
|
Jun 01, 2017 01:49PM
|
|
Mark Day interview with Stock News Now
|
4
|
BIOASIS TECHNOLOGIES INC
|
Feb 27, 2019 01:53PM
|
|
Resverlogix presentation at European Meeting on Complement in Human Disease meeting
|
4
|
Resverlogix Corp.
|
Sep 08, 2017 03:01PM
|
|
Re: Reata, Friedreich’s Ataxia and Kidney Disease
|
4
|
Resverlogix Corp.
|
Oct 17, 2019 10:55PM
|
|
Re: New Share Price Contest update to Oct 12th
|
4
|
Resverlogix Corp.
|
Oct 13, 2019 10:06AM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 06:11PM
|
|
Re: Short interest creeps up again.....
|
4
|
Resverlogix Corp.
|
Apr 20, 2017 01:13PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
4
|
Resverlogix Corp.
|
Sep 07, 2019 05:25PM
|
|
Re: Estimated Glomerular Filtration Rate
|
4
|
Resverlogix Corp.
|
Nov 17, 2019 06:14PM
|
|
Re: so what happens if dm fumbles the ball??
|
4
|
Resverlogix Corp.
|
Jul 12, 2020 05:59PM
|
|
Re: While we wait, outside items that may be of interest
|
4
|
Resverlogix Corp.
|
Aug 29, 2017 07:42AM
|
|
Re: Pfizer working with Zenith but not Resverlogix....Is 3 a crowd?
|
4
|
Resverlogix Corp.
|
Jun 29, 2019 06:17PM
|
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
4
|
Resverlogix Corp.
|
Oct 31, 2016 10:46PM
|
